Latest Articles

Publication Date
Lisata Therapeutics partners with University of Cincinnati to investigate endometriosis therapy - ICYMI - Proactive Investors USA

Lisata Therapeutics partners with University of Cincinnati to investigate endometriosis therapy - ICYMI Proactive Investors USA

Published: Nov. 2, 2024, noon
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - ca.proactiveinvestors.com

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis ca.proactiveinvestors.com

Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive financial news

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive financial news

Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis - Proactive Investors USA

Lisata Therapeutics, University of Cincinnati explore combination treatment for Endometriosis Proactive Investors USA

Published: Oct. 31, 2024, 5:16 p.m.
Lisata Therapeutics Announces Sponsored Preclinical - GlobeNewswire

Lisata Therapeutics Announces Sponsored Preclinical GlobeNewswire

Published: Oct. 28, 2024, 2:42 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive financial news

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive financial news

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors USA

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors USA

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia

Published: Oct. 28, 2024, 1:52 p.m.
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan

Published: Oct. 28, 2024, 12:30 p.m.
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) The Manila Times

Published: Oct. 16, 2024, 8:24 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!